{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T04:50:19Z","timestamp":1794199819555,"version":"4.8.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T00:00:00Z","timestamp":1627948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T00:00:00Z","timestamp":1627948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Polycystic liver disease is a clinical feature of autosomal dominant polycystic kidney disease, and it can sometimes cause health damage more serious than polycystic kidney. Dialysis therapy can be used for renal failure, but liver transplantation is the only method available for liver failure. Thus, giant and multiple hepatic cysts may affect mortality. However, liver transplantation is not indicated in many cases because of the preserved liver function.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 54-year-old Japanese woman with polycystic liver disease was transferred back to our hospital for abdominal pain caused by liver cyst infection with abdominal wall herniation. She had been diagnosed with polycystic liver disease associated with sporadic autosomal dominant polycystic kidney disease 25\u00a0years earlier. Although she had several surgical interventions to reduce her liver volume, including right hepatic lobectomy and fenestration for liver cysts in another hospital, she needed further repair of the recurrent incisional herniation with patch graft surgery using fascia lata to cover the herniation site. However, new herniation sites reemerged in the fragile abdominal wall area around the patch, and therefore, she reduced the recurrent abdominal wall herniation by herself. Recurrent intestinal obstructions were luckily released by fasting with decompression treatment via nasogastric tube insertion, but multiple skin ulcers around the enlarged hernia sac gradually developed, and ascites was extremely difficult to control with any medication. At final admission, her abdominal wall was even more prominent, causing shortness of breath, and it spontaneously ruptured many times, which was accompanied by discharge of around 5\u00a0liters of ascites each time. She died from sepsis caused by drug-resistant <jats:italic>Enterococcus<\/jats:italic>.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We report a case of autosomal dominant polycystic kidney disease with ruptured abdominal wall resulting from a hepatic cyst enlargement despite multiple laparotomy operations. Throughout the entire disease course, her liver volume increased rapidly, and her quality of life was severely impaired, but she could not undergo liver transplantation after readmission to our hospital. We will discuss the therapeutic strategy for this patient, including the timing and indication for liver transplantation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-021-02964-6","type":"journal-article","created":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T03:42:33Z","timestamp":1627962153000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Polycystic liver disease with lethal abdominal wall rupture: a case report"],"prefix":"10.1186","volume":"15","author":[{"given":"Daichi","family":"Akuzawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichiro","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Ishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Kakita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Terajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,3]]},"reference":[{"issue":"48","key":"2964_CR1","doi-asserted-by":"publisher","first-page":"7690","DOI":"10.3748\/wjg.v11.i48.7690","volume":"11","author":"R Peces","year":"2005","unstructured":"Peces R, Drenth JP, Te Morsche RH, Gonzalez P, Peces C. Autosomal dominant polycystic liver disease in a family without polycystic kidney disease associated with a novel missense protein kinase C substrate 80K-H mutation. World J Gastroenterol. 2005;11(48):7690\u20133.","journal-title":"World J Gastroenterol"},{"issue":"35","key":"2964_CR2","doi-asserted-by":"publisher","first-page":"5775","DOI":"10.3748\/wjg.v19.i35.5775","volume":"19","author":"B Abu-Wasel","year":"2013","unstructured":"Abu-Wasel B, Walsh C, Keough V, Molinari M. Pathophysiology, epidemiology, classification and treatment options for polycystic liver diseases. World J Gastroenterol. 2013;19(35):5775\u201386.","journal-title":"World J Gastroenterol"},{"issue":"11","key":"2964_CR3","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.2215\/CJN.03960318","volume":"13","author":"FT Chebib","year":"2018","unstructured":"Chebib FT, Torres VE. Recent advances in the management of autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2018;13(11):1765\u201376.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"2964_CR4","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s10620-009-0776-6","volume":"55","author":"AM Yang","year":"2010","unstructured":"Yang AM, Shih SC, Chu CH, Wang TE, Yang WS. PRKCSH genetic mutation was not found in Taiwanese patients with polycystic liver disease. Dig Dis Sci. 2010;55(3):815\u20139.","journal-title":"Dig Dis Sci"},{"issue":"10","key":"2964_CR5","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1681\/ASN.2018050493","volume":"29","author":"MB Lanktree","year":"2018","unstructured":"Lanktree MB, Haghighi A, Guiard E, Iliuta IA, Song X, Harris PC, et\u00a0al. Prevalence estimates of polycystic kidney and liver disease by population sequencing. J Am Soc Nephrol. 2018;29(10):2593\u2013600.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"2964_CR6","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/ng1357","volume":"36","author":"S Davila","year":"2004","unstructured":"Davila S, Furu L, Gharavi AG, Tian X, Onoe T, Qian Q, et\u00a0al. Mutations in SEC63 cause autosomal dominant polycystic liver disease. Nat Genet. 2004;36(6):575\u20137.","journal-title":"Nat Genet"},{"issue":"7","key":"2964_CR7","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/ng.860","volume":"43","author":"SV Fedeles","year":"2011","unstructured":"Fedeles SV, Tian X, Gallagher AR, Mitobe M, Nishio S, Lee SH, et\u00a0al. A genetic interaction network of five genes for human polycystic kidney and liver diseases defines polycystin-1 as the central determinant of cyst formation. Nat Genet. 2011;43(7):639\u201347.","journal-title":"Nat Genet"},{"issue":"12","key":"2964_CR8","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/nrgastro.2014.155","volume":"11","author":"MJ Perugorria","year":"2014","unstructured":"Perugorria MJ, Masyuk TV, Marin JJ, Marzioni M, Bujanda L, LaRusso NF, et\u00a0al. Polycystic liver diseases: advanced insights into the molecular mechanisms. Nat Rev Gastroenterol Hepatol. 2014;11(12):750\u201361.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"2964_CR9","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1172\/JCI90129","volume":"127","author":"W Besse","year":"2017","unstructured":"Besse W, Dong K, Choi J, Punia S, Fedeles SV, Choi M, et\u00a0al. Isolated polycystic liver disease genes define effectors of polycystin-1 function. J Clin Invest. 2017;127(5):1772\u201385.","journal-title":"J Clin Invest"},{"issue":"10174","key":"2964_CR10","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S0140-6736(18)32782-X","volume":"393","author":"E Cornec-Le Gall","year":"2019","unstructured":"Cornec-Le Gall E, Alam A, Perrone RD. Autosomal dominant polycystic kidney disease. Lancet. 2019;393(10174):919\u201335.","journal-title":"Lancet"},{"issue":"6","key":"2964_CR11","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1002\/hep.1840110619","volume":"11","author":"PA Gabow","year":"1990","unstructured":"Gabow PA, Johnson AM, Kaehny WD, Manco-Johnson ML, Duley IT, Everson GT. Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease. Hepatology. 1990;11(6):1033\u20137.","journal-title":"Hepatology"},{"issue":"6","key":"2964_CR12","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/ki.2011.411","volume":"81","author":"VE Torres","year":"2012","unstructured":"Torres VE, Chapman AB, Perrone RD, Bae KT, Abebe KZ, Bost JE, et\u00a0al. Analysis of baseline parameters in the HALT polycystic kidney disease trials. Kidney Int. 2012;81(6):577\u201385.","journal-title":"Kidney Int"},{"key":"2964_CR13","doi-asserted-by":"crossref","unstructured":"Besse W, Chang AR, Luo JZ, Triffo WJ, Moore BS, Gulati A, et\u00a0al. ALG9 mutation carriers develop kidney and liver cysts. J Am Soc Nephrol. 2019.","DOI":"10.1681\/ASN.2019030298"},{"issue":"6","key":"2964_CR14","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1093\/ndt\/gfw008","volume":"31","author":"FT Chebib","year":"2016","unstructured":"Chebib FT, Jung Y, Heyer CM, Irazabal MV, Hogan MC, Harris PC, et\u00a0al. Effect of genotype on the severity and volume progression of polycystic liver disease in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant. 2016;31(6):952\u201360.","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"2964_CR15","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/00000658-199703000-00008","volume":"225","author":"JF Gigot","year":"1997","unstructured":"Gigot JF, Jadoul P, Que F, Van Beers BE, Etienne J, Horsmans Y, et\u00a0al. Adult polycystic liver disease: is fenestration the most adequate operation for long-term management? Ann Surg. 1997;225(3):286\u201394.","journal-title":"Ann Surg"},{"issue":"6","key":"2964_CR16","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1002\/hep.24036","volume":"52","author":"JP Drenth","year":"2010","unstructured":"Drenth JP, Chrispijn M, Nagorney DM, Kamath PS, Torres VE. Medical and surgical treatment options for polycystic liver disease. Hepatology. 2010;52(6):2223\u201330.","journal-title":"Hepatology"},{"issue":"4","key":"2964_CR17","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/hep.1840400404","volume":"40","author":"GT Everson","year":"2004","unstructured":"Everson GT, Taylor MR, Doctor RB. Polycystic disease of the liver. Hepatology. 2004;40(4):774\u201382.","journal-title":"Hepatology"},{"issue":"1","key":"2964_CR18","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/SLA.0b013e3181ad83dc","volume":"250","author":"T Schnelldorfer","year":"2009","unstructured":"Schnelldorfer T, Torres VE, Zakaria S, Rosen CB, Nagorney DM. Polycystic liver disease: a critical appraisal of hepatic resection, cyst fenestration, and liver transplantation. Ann Surg. 2009;250(1):112\u20138.","journal-title":"Ann Surg"},{"key":"2964_CR19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1750-1172-9-69","volume":"9","author":"WR Cnossen","year":"2014","unstructured":"Cnossen WR, Drenth JP. Polycystic liver disease: an overview of pathogenesis, clinical manifestations and management. Orphanet J Rare Dis. 2014;9:69.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2964_CR20","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jamcollsurg.2015.12.051","volume":"223","author":"FT Chebib","year":"2016","unstructured":"Chebib FT, Harmon A, Irazabal Mira MV, Jung YS, Edwards ME, Hogan MC, et\u00a0al. Outcomes and durability of hepatic reduction after combined partial hepatectomy and cyst fenestration for massive polycystic liver disease. J Am Coll Surg. 2016;223(1):118\u201326.","journal-title":"J Am Coll Surg."},{"issue":"1","key":"2964_CR21","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2214\/AJR.16.16130","volume":"208","author":"TF Wijnands","year":"2017","unstructured":"Wijnands TF, Gortjes AP, Gevers TJ, Jenniskens SF, Kool LJ, Potthoff A, et\u00a0al. Efficacy and safety of aspiration sclerotherapy of simple hepatic cysts: a systematic review. AJR Am J Roentgenol. 2017;208(1):201\u20137.","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"2964_CR22","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.jhep.2017.11.024","volume":"68","author":"RMM van Aerts","year":"2018","unstructured":"van Aerts RMM, van de Laarschot LFM, Banales JM, Drenth JPH. Clinical management of polycystic liver disease. J Hepatol. 2018;68(4):827\u201337.","journal-title":"J Hepatol"},{"issue":"3","key":"2964_CR23","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1097\/01.TP.0000110319.60723.31","volume":"77","author":"M Ueda","year":"2004","unstructured":"Ueda M, Egawa H, Oike F, Taira K, Uryuhara K, Fujimoto Y, et\u00a0al. Living-donor liver transplantation for polycystic liver disease. Transplantation. 2004;77(3):480\u20131.","journal-title":"Transplantation"},{"issue":"6","key":"2964_CR24","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1148\/rg.266065013","volume":"26","author":"DE Morgan","year":"2006","unstructured":"Morgan DE, Lockhart ME, Canon CL, Holcombe MP, Bynon JS. Polycystic liver disease: multimodality imaging for complications and transplant evaluation. Radiographics. 2006;26(6):1655\u201368.","journal-title":"Radiographics."},{"issue":"3","key":"2964_CR25","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.transproceed.2017.01.033","volume":"49","author":"S Acar","year":"2017","unstructured":"Acar S, Gencdal G, Tokac M, Eren E, Alkara U, Tellioglu G, et\u00a0al. Liver transplantation for polycystic liver disease due to huge liver with related complications: a case report. Transplant Proc. 2017;49(3):603\u20135.","journal-title":"Transplant Proc"},{"issue":"7","key":"2964_CR26","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1016\/j.transproceed.2012.06.041","volume":"44","author":"E Gringeri","year":"2012","unstructured":"Gringeri E, D\u2019Amico FE, Bassi D, Mescoli C, Bonsignore P, Boetto R, et\u00a0al. Liver transplantation for massive hepatomegaly due to polycystic liver disease: an extreme case. Transplant Proc. 2012;44(7):2038\u201340.","journal-title":"Transplant Proc"},{"issue":"8","key":"2964_CR27","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1002\/lt.20780","volume":"12","author":"GI Kirchner","year":"2006","unstructured":"Kirchner GI, Rifai K, Cantz T, Nashan B, Terkamp C, Becker T, et\u00a0al. Outcome and quality of life in patients with polycystic liver disease after liver or combined liver-kidney transplantation. Liver Transpl. 2006;12(8):1268\u201377.","journal-title":"Liver Transpl"},{"issue":"2","key":"2964_CR28","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s13730-018-0348-8","volume":"7","author":"T Akihisa","year":"2018","unstructured":"Akihisa T, Ino A, Egawa H, Kotera Y, Ariizumi S, Oomori A, et\u00a0al. A case of a maintenance hemodialysis patient with autosomal dominant polycystic kidney disease who underwent living donor liver transplantation alone due to refractory liver cyst infection. CEN Case Rep. 2018;7(2):307\u201312.","journal-title":"CEN Case Rep."},{"issue":"6","key":"2964_CR29","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1053\/j.ajkd.2007.03.018","volume":"49","author":"R Takei","year":"2007","unstructured":"Takei R, Ubara Y, Hoshino J, Higa Y, Suwabe T, Sogawa Y, et\u00a0al. Percutaneous transcatheter hepatic artery embolization for liver cysts in autosomal dominant polycystic kidney disease. Am J Kidney Dis. 2007;49(6):744\u201352.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"2964_CR30","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1681\/ASN.2007050626","volume":"19","author":"Q Qian","year":"2008","unstructured":"Qian Q, Du H, King BF, Kumar S, Dean PG, Cosio FG, et\u00a0al. Sirolimus reduces polycystic liver volume in ADPKD patients. J Am Soc Nephrol. 2008;19(3):631\u20138.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2964_CR31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1308\/rcsann.2016.0023","volume":"98","author":"S Khan","year":"2016","unstructured":"Khan S, Dennison A, Garcea G. Medical therapy for polycystic liver disease. Ann R Coll Surg Engl. 2016;98(1):18\u201323.","journal-title":"Ann R Coll Surg Engl"},{"issue":"9","key":"2964_CR32","doi-asserted-by":"publisher","first-page":"3532","DOI":"10.1093\/ndt\/gfs152","volume":"27","author":"MC Hogan","year":"2012","unstructured":"Hogan MC, Masyuk TV, Page L, Holmes DR 3rd, Li X, Bergstralh EJ, et\u00a0al. Somatostatin analog therapy for severe polycystic liver disease: results after 2 years. Nephrol Dial Transplant. 2012;27(9):3532\u20139.","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"2964_CR33","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.cgh.2015.12.049","volume":"14","author":"A Pisani","year":"2016","unstructured":"Pisani A, Sabbatini M, Imbriaco M, Riccio E, Rubis N, Prinster A, et\u00a0al. Long-term effects of octreotide on liver volume in patients with polycystic kidney and liver disease. Clin Gastroenterol Hepatol. 2016;14(7):1022\u201330.","journal-title":"Clin Gastroenterol Hepatol."}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-021-02964-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-021-02964-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-021-02964-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T03:43:01Z","timestamp":1627962181000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-021-02964-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,3]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2964"],"URL":"https:\/\/doi.org\/10.1186\/s13256-021-02964-6","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,3]]},"assertion":[{"value":"12 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Th ethical committee at Kitano Hospital provided approvals for this case report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Before her death, the patient and her family provided written informed consent for her personal and clinical details along with any identifying images to be published in this case report. Written informed consent was obtained from the patient\u2018s next of kin for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"421"}}